Skip to main content
Aprogen, Inc logo

Aprogen, Inc — Investor Relations & Filings

Ticker · 007460 ISIN · KR7007460009 KO Manufacturing
Open in API
Filings indexed 734 across all filing types
Latest filing 2024-09-19 M&A Activity
Country KR South Korea
Listing KO 007460

About Aprogen, Inc

https://www.aprogen.com/en/v.do?a=Main

Aprogen, Inc. is a biopharmaceutical company focused on the research, development, and manufacturing of biologic medicines. The company's core activities are centered on developing both biosimilars and novel drugs, including new protein therapeutics and bispecific antibodies. Its product development is based on proprietary technologies in antibody engineering and recombinant protein engineering.

Recent filings

Filing Released Lang Actions
투자판단관련주요경영사항
M&A Activity Classification · 100% confidence The document is a regulatory filing from the Korean company 'Aprogen' regarding a 'Major Management Matter' (투자판단 관련 주요경영사항). It details a joint development agreement for a biosimilar product (AP096) with another entity (AP Healthcare). Since this is a specific corporate announcement regarding a business contract/partnership that does not fit into the other specialized categories like M&A or financial reports, it is classified as a general regulatory filing.
2024-09-19 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (often referred to as a 5% rule filing). It details the changes in share ownership by Sangsangin Savings Bank and its related parties in Aprogen. This falls under the 'Major Shareholding Notification' category, as it tracks significant changes in ownership levels and potential voting power.
2024-09-10 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. This document tracks significant changes in share ownership (5% rule) and is classified as a Major Shareholding Notification (MRQ) in our system.
2024-08-30 Korean
[기재정정]기업지배구조보고서공시
Governance Information Classification · 100% confidence The document is a 'Corporate Governance Report' (기업지배구조보고서) which details the company's governance structure, shareholder rights, and compliance with governance indicators. It also includes a 'Correction Report' (정정신고) header, indicating it is an amendment to a previously filed governance report. In the context of financial filings, Corporate Governance Reports are classified under Governance Information.
2024-08-23 Korean
[기재정정]타법인주식및출자증권처분결정
Capital/Financing Update Classification · 95% confidence The document is a regulatory filing from a Korean company (Aprogen) regarding the 'Disposal of Shares and Securities of Other Corporations' (타법인주식및출자증권처분결정). It is a correction filing (정정신고) detailing changes in share disposal quantities and amounts. This type of corporate disclosure regarding asset disposal or investment changes does not fit into specific categories like M&A (which usually implies control changes or mergers) or Share Issues (SHA). Therefore, it falls under the general regulatory filing category.
2024-08-20 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership, and contractual relationships (such as collateral agreements) of major shareholders. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2024-08-16 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.